Hematin, an iron-containing porphyrin, inhibits the activity of clotting factors and also fibrin clot lysis through the mechanism of binding to and inactivation of hemostatic proteins. Hematin can be used for the research of acute porphyrias and cancer.
性状
Solid
体外研究(In Vitro)
Hematin (0.01 mg/ml) inhibits the clotting of bovine fibrinogen (1.3 to 2.6 mg/ml) by bovine thrombin (0.12 U/ml) and inhibits the hydrolysis of a synthetic substrate by human thrombin.Hematin (0.035 mg/ml) reduces VIII:C activity from 0.88 to 0.40 U/ml.Hematin (0.05 mg/ml) inhibits the activation of VIII:C by thrombin (0.04 U/ml).Hematin (0.09 mg/ml) inhibits the hydrolysis of a synthetic substrate by plasmin. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Hematin (i.v.; single injection) suppressed porphyrin production in SD rat (weighing 160-205 g). has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Siegert SW, et al. Physicochemical properties, pharmacokinetics, and pharmacodynamics of intravenous hematin: a literature review. Adv Ther. 2008 Sep;25(9):842-57.[2]. Green D, et al. The inactivation of hemostatic factors by hematin. J Lab Clin Med. 1983;102: 361-369.[3]. Amin ML, et al. Development of hemat
溶解度数据
In Vitro: DMSO : 1.43 mg/mL (2.26 mM; ultrasonic and warming and heat to 70°C)配制储备液